Bolt Biotherapeutics, Inc. (BOLT) dividend history
BOLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/3030% below fair value
$6.08+0.17 (+2.88%)
Close on Nov 13, 2026Market cap $11.71MP/E –Yield –
Dividends
Bolt Biotherapeutics has not reported a dividend
No dividend per share appears in Bolt Biotherapeutics's annual filings since fiscal 2019.
See a number that looks wrong?